Seeking the technology of automated control of quality of 1 liter milk bags sealing
Ready to Market Technical Innovations and ProductsProject Size Range : 50,000 - 250,000 €
Pavan KumarPavan Kumar Suprita DashSuprita Dash
Biótica, Bioquímica Analítica,S.L.Biótica, Bioquímica Analítica,S.L.Biótica, Bioquímica Analítica,S.L.
Small and Medium Enterprise from Spain · Castellón
Biótica´s mission is to enhance client´s ability to timely assess the microbiological risk and to optimize its prevention strategy thanks to fast, reliable, simple and low-cost microbial determination. Established in September 2005, Biótica has in its years of existence successfully transitioned from the status of a start-up to that of a SME. Biótica is the first biotechnological company located at Science and Technology Park of Jaume I University, since 2009. The company focused on the development of fast microbial detection techniques combining immunomagnetic capture and enzyme immunoassay (C.E.I.A.). Biótica developed the first and only fast test certified by AOAC RI, in 2011, to detect Legionella in water, named Legipid® Legionella Fast Detection. Recently, new automated devices have also been developed, based on this technology., as a result of a european project SME Instrument Phase II - H2020. The market of this test and related automated devices comprises the following areas: Industries Commercial/Private Labs, Physician Offices, Public Health Labs, Hospitals, Hotels, spas, jacuzzis, swimming-pools, Recreational areas, sport areas (golf,etc), Companies providing testing and analysis of environmental water samples for Legionella Companies providing monitoring critical points with simple interpretation of results, Companies providing cleaning & disinfecting water services, Companies providing Legionella managing plan and risk assessment, Providers of integrated water treatment and process improvement services, chemicals and equipment programmes for industrial and institutional applications, Manufacturers of tools for microbiology laboratories.
IDIBELLIDIBELLIDIBELL
Technology Transfer Office from Spain
The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center established in 2004, located in L’Hospitalet de Llobregat, south of Barcelona, Spain. Its stakeholders are Bellvitge University Hospital and Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, University of Barcelona and the City of L’Hospitalet de Llobregat. IDIBELL comprises more than 1200 researchers integrated in 67 research groups strategically organized in 4 scientific areas: Cancer, Neurosciences, Translational and Regenative Medicine. The IDIBELL Core Research Facilities include a set of centralized platforms dedicated to developing and providing research resources to assist campus biomedical researchers, such as: biobank, proteomics unit, genomics unit, cytomics unit, C. elegans facility, animal facility, statistical assessment for researchers, Clinical research unit (UICEC) and biomarkers platform. Through these different resources, IDIBELL would like to supply equipment and instrumentation, technical expertise and training to promote innovative, cutting edge research. IDIBELL has the purpose of connecting academia and industry in order to promote innovative ideas to the market and therefore to society, by supporting professionals along the process. triveni scholarstriveni scholars
Rasha AlkordyRasha Alkordy